Literature DB >> 30930569

Validity and reliability of the 20-m run, horizontal leap, and four-bound tests measuring high-level mobility in neurologically impaired patients.

Marek Gorski1, Grant Scroggie1, Terrence Haines1.   

Abstract

BACKGROUND: High-level mobility (HLM) training including running forms an integral part of physical rehabilitation for neurologically impaired patients.
OBJECTIVE: This study examines the validity and reliability of three quickly administrable measures of HLM, namely, the 20-m run, horizontal leap, and four-bound tests in patients with neurological disorders.
METHODS: This is a retrospective data audit of 62 patients (23 women, 37.1%; 39 men, 62.9%) participating in the HLM (running retraining) task. All participants were recovering from neurological conditions such as stroke, brain injury, brain/spinal tumour, Guillain-Barré syndrome, and cerebral palsy complications.
RESULTS: High levels of test-retest reliability of the investigated tests (interclass correlation coefficient > 0.95) were obtained. The 95% minimum detectable changes were as follows: 20-m run, 1.9 seconds; horizontal leap, 0.20 m; four-bound test, 0.57 m. The area under the receiver-operated characteristic curve was 0.96 for the 20-m run, 0.90 for the horizontal leap, and 0.91 for the four-bound test, which suggests high validity of the tests to discriminate between participants who were classified as "running" and those as "not running". Participants performing at < 7.2 seconds for the 20-m run test or ≥ 0.75 m for the horizontal leap test or 4.0 m for the four-bound test were most likely classified as running.
CONCLUSION: The 20-m run, horizontal leap, and four-bound tests are valid and reliable objective measures of HLM when administered in people with neurological conditions.

Entities:  

Keywords:  high-level mobility; neurological conditions; rehabilitation; running retraining

Year:  2015        PMID: 30930569      PMCID: PMC6385131          DOI: 10.1016/j.hkpj.2015.03.003

Source DB:  PubMed          Journal:  Hong Kong Physiother J        ISSN: 1013-7025


  23 in total

1.  Mobility-related function in older adults: assessment with a 6-minute walk test.

Authors:  N D Harada; V Chiu; A L Stewart
Journal:  Arch Phys Med Rehabil       Date:  1999-07       Impact factor: 3.966

2.  The biomechanics of running.

Authors: 
Journal:  Gait Posture       Date:  1998-01-01       Impact factor: 2.840

3.  Validity of motor tasks for predicting running ability in acquired brain injury.

Authors:  G Williams; P Goldie
Journal:  Brain Inj       Date:  2001-09       Impact factor: 2.311

4.  Additional task-related practice improves mobility and upper limb function early after stroke: a randomised controlled trial.

Authors:  Jannette Blennerhassett; Wayne Dite
Journal:  Aust J Physiother       Date:  2004

Review 5.  Measuring high-level mobility after traumatic brain injury.

Authors:  Gavin Williams; Val Robertson; Ken Greenwood
Journal:  Am J Phys Med Rehabil       Date:  2004-12       Impact factor: 2.159

6.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

7.  Use of visual feedback in retraining balance following acute stroke.

Authors:  C Walker; B J Brouwer; E G Culham
Journal:  Phys Ther       Date:  2000-09

8.  Cardiorespiratory fitness and walking ability in subacute stroke patients.

Authors:  Joanna O Kelly; Sharon L Kilbreath; Glen M Davis; Brian Zeman; Jacqui Raymond
Journal:  Arch Phys Med Rehabil       Date:  2003-12       Impact factor: 3.966

9.  Submaximal exercise in persons with stroke: test-retest reliability and concurrent validity with maximal oxygen consumption.

Authors:  Janice J Eng; Andrew S Dawson; Kelly S Chu
Journal:  Arch Phys Med Rehabil       Date:  2004-01       Impact factor: 3.966

10.  A task-orientated intervention enhances walking distance and speed in the first year post stroke: a randomized controlled trial.

Authors:  N M Salbach; N E Mayo; S Wood-Dauphinee; J A Hanley; C L Richards; R Côté
Journal:  Clin Rehabil       Date:  2004-08       Impact factor: 3.477

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.